These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 12695731

  • 1. Placebo response and antidepressant clinical trial outcome.
    Khan A, Detke M, Khan SR, Mallinckrodt C.
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [Abstract] [Full Text] [Related]

  • 2. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A, Schwartz K, Kolts RL, Ridgway D, Lineberry C.
    Biol Psychiatry; 2007 Jul 01; 62(1):65-71. PubMed ID: 17141744
    [Abstract] [Full Text] [Related]

  • 3. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA, Chen YF, Yang Y, Yang P, Laughren TP.
    J Clin Psychiatry; 2011 Apr 01; 72(4):464-72. PubMed ID: 21527123
    [Abstract] [Full Text] [Related]

  • 4. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A.
    Mol Interv; 2002 Apr 01; 2(2):72-6. PubMed ID: 14993352
    [No Abstract] [Full Text] [Related]

  • 5. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA, Reimitz PE, Sennef C.
    Psychopharmacol Bull; 1997 Apr 01; 33(1):41-51. PubMed ID: 9133750
    [Abstract] [Full Text] [Related]

  • 6. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A, Brodhead AE, Kolts RL, Brown WA.
    J Psychiatr Res; 2005 Mar 01; 39(2):145-50. PubMed ID: 15589562
    [Abstract] [Full Text] [Related]

  • 7. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
    Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctôt KL.
    J Clin Psychiatry; 2010 Mar 01; 71(3):270-9. PubMed ID: 20122371
    [Abstract] [Full Text] [Related]

  • 8. Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration.
    Khin NA, Chen YF, Yang Y, Yang P, Laughren TP.
    J Clin Psychiatry; 2012 Jun 01; 73(6):856-64. PubMed ID: 22687813
    [Abstract] [Full Text] [Related]

  • 9. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
    Papakostas GI, Fava M.
    Eur Neuropsychopharmacol; 2009 Jan 01; 19(1):34-40. PubMed ID: 18823760
    [Abstract] [Full Text] [Related]

  • 10. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K.
    Arch Gen Psychiatry; 2004 Dec 01; 61(12):1235-44. PubMed ID: 15583115
    [Abstract] [Full Text] [Related]

  • 11. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug 01; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA, Masand PS, Pae CU, Peindl K, Hooper-Wood C, Mannelli P, Ciccone P.
    J Clin Psychopharmacol; 2006 Dec 01; 26(6):653-6. PubMed ID: 17110825
    [Abstract] [Full Text] [Related]

  • 13. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI, McFall JP.
    J Nerv Ment Dis; 2006 Nov 01; 194(11):845-52. PubMed ID: 17102709
    [Abstract] [Full Text] [Related]

  • 14. Review of placebo-controlled trials with bupropion.
    Zung WW.
    J Clin Psychiatry; 1983 May 01; 44(5 Pt 2):104-14. PubMed ID: 6406436
    [Abstract] [Full Text] [Related]

  • 15. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N, Rubinow DR.
    Arch Gen Psychiatry; 2005 Feb 01; 62(2):154-62. PubMed ID: 15699292
    [Abstract] [Full Text] [Related]

  • 16. Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database.
    Khan A, Leventhal RM, Khan SR, Brown WA.
    J Clin Psychopharmacol; 2002 Feb 01; 22(1):40-5. PubMed ID: 11799341
    [Abstract] [Full Text] [Related]

  • 17. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT, Isaac MB, Gallo F, Tournoux A.
    Hum Psychopharmacol; 2003 Dec 01; 18(8):595-601. PubMed ID: 14696018
    [Abstract] [Full Text] [Related]

  • 18. The persistence of the placebo response in antidepressant clinical trials.
    Khan A, Redding N, Brown WA.
    J Psychiatr Res; 2008 Aug 01; 42(10):791-6. PubMed ID: 18036616
    [Abstract] [Full Text] [Related]

  • 19. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J, MIND-IT investigators.
    Psychosom Med; 2007 Aug 01; 69(7):606-13. PubMed ID: 17846258
    [Abstract] [Full Text] [Related]

  • 20. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH, Watkin JG, Liu C, Wohlreich MM, Raskin J.
    BMC Psychiatry; 2005 Jan 04; 5():1. PubMed ID: 15631624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.